Yan Sun1,2,3, Jonathan O Lipton1,4, Lara M Boyle1, Joseph R Madsen5, Marti C Goldenberg1, Alvaro Pascual-Leone6, Mustafa Sahin1, Alexander Rotenberg1,2,6. 1. Department of Neurology and F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA. 2. Neuromodulation Program, Boston Children's Hospital, Boston, MA. 3. Program in Neuroscience, Harvard Medical School, Boston, MA. 4. Division of Sleep Medicine, Harvard Medical School, Boston, MA. 5. Department of Neurosurgery, Boston Children's Hospital, Boston, MA. 6. Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: To obtain insights into mechanisms mediating changes in cortical excitability induced by cathodal transcranial direct current stimulation (tDCS). METHODS: Neocortical slices were exposed to direct current stimulation (DCS) delivered through Ag/AgCl electrodes over a range of current orientations, magnitudes, and durations. DCS-induced cortical plasticity and its receptor dependency were measured as the change in layer II/III field excitatory postsynaptic potentials by a multielectrode array, both with and without neurotransmitter receptor blockers or allosteric modulators. In vivo, tDCS was delivered to intact mice scalp via surface electrodes. Molecular consequences of DCS in vitro or tDCS in vivo were tested by immunoblot of protein extracted from stimulated slices or the neocortex harvested from stimulated intact mice. RESULTS: Cathodal DCS in vitro induces a long-term depression (DCS-LTD) of excitatory synaptic strength in both human and mouse neocortical slices. DCS-LTD is abolished with an mGluR5 negative allosteric modulator, mechanistic target of rapamycin (mTOR) inhibitor, and inhibitor of protein synthesis. However, DCS-LTD persists despite either γ-aminobutyric acid type A receptor or N-methyl-D-aspartate receptor inhibition. An mGluR5-positive allosteric modulator, in contrast, transformed transient synaptic depression resultant from brief DCS application into durable DCS-LTD. INTERPRETATION: We identify a novel molecular pathway by which tDCS modulates cortical excitability, and indicate a capacity for synergistic interaction between tDCS and pharmacologic mGluR5 facilitation. The findings support exploration of cathodal tDCS as a treatment of neurologic conditions characterized by aberrant regional cortical excitability referable to mGluR5-mTOR signaling. Ann Neurol 2016;80:233-246.
OBJECTIVE: To obtain insights into mechanisms mediating changes in cortical excitability induced by cathodal transcranial direct current stimulation (tDCS). METHODS: Neocortical slices were exposed to direct current stimulation (DCS) delivered through Ag/AgCl electrodes over a range of current orientations, magnitudes, and durations. DCS-induced cortical plasticity and its receptor dependency were measured as the change in layer II/III field excitatory postsynaptic potentials by a multielectrode array, both with and without neurotransmitter receptor blockers or allosteric modulators. In vivo, tDCS was delivered to intact mice scalp via surface electrodes. Molecular consequences of DCS in vitro or tDCS in vivo were tested by immunoblot of protein extracted from stimulated slices or the neocortex harvested from stimulated intact mice. RESULTS:Cathodal DCS in vitro induces a long-term depression (DCS-LTD) of excitatory synaptic strength in both human and mouse neocortical slices. DCS-LTD is abolished with an mGluR5 negative allosteric modulator, mechanistic target of rapamycin (mTOR) inhibitor, and inhibitor of protein synthesis. However, DCS-LTD persists despite either γ-aminobutyric acid type A receptor or N-methyl-D-aspartate receptor inhibition. An mGluR5-positive allosteric modulator, in contrast, transformed transient synaptic depression resultant from brief DCS application into durable DCS-LTD. INTERPRETATION: We identify a novel molecular pathway by which tDCS modulates cortical excitability, and indicate a capacity for synergistic interaction between tDCS and pharmacologic mGluR5 facilitation. The findings support exploration of cathodal tDCS as a treatment of neurologic conditions characterized by aberrant regional cortical excitability referable to mGluR5-mTOR signaling. Ann Neurol 2016;80:233-246.
Authors: Sudar Alagarsamy; Julie Saugstad; Lee Warren; Isabelle M Mansuy; Robert W Gereau; P Jeffrey Conn Journal: Neuropharmacology Date: 2005 Impact factor: 5.250
Authors: Chiara Verpelli; Elena Dvoretskova; Cinzia Vicidomini; Francesca Rossi; Michela Chiappalone; Michael Schoen; Bruno Di Stefano; Renato Mantegazza; Vania Broccoli; Tobias M Böckers; Alexander Dityatev; Carlo Sala Journal: J Biol Chem Date: 2011-07-27 Impact factor: 5.157
Authors: Zeinab Esmaeilpour; Paola Marangolo; Benjamin M Hampstead; Sven Bestmann; Elisabeth Galletta; Helena Knotkova; Marom Bikson Journal: Brain Stimul Date: 2017-12-13 Impact factor: 8.955
Authors: Mustafa Q Hameed; Sameer C Dhamne; Roman Gersner; Harper L Kaye; Lindsay M Oberman; Alvaro Pascual-Leone; Alexander Rotenberg Journal: Curr Neurol Neurosci Rep Date: 2017-02 Impact factor: 5.081
Authors: Georgia H O'Leary; Dorothea D Jenkins; Patricia Coker-Bolt; Mark S George; Steve Kautz; Marom Bikson; Bernadette T Gillick; Bashar W Badran Journal: Prog Brain Res Date: 2021-02-23 Impact factor: 2.624
Authors: Marom Bikson; Andre R Brunoni; Leigh E Charvet; Vincent P Clark; Leonardo G Cohen; Zhi-De Deng; Jacek Dmochowski; Dylan J Edwards; Flavio Frohlich; Emily S Kappenman; Kelvin O Lim; Colleen Loo; Antonio Mantovani; David P McMullen; Lucas C Parra; Michele Pearson; Jessica D Richardson; Judith M Rumsey; Pejman Sehatpour; David Sommers; Gozde Unal; Eric M Wassermann; Adam J Woods; Sarah H Lisanby Journal: Brain Stimul Date: 2017-12-29 Impact factor: 8.955